Dr. Barry Dworkin

New medication in the research pipeline designed to improve upon the efficacy of semaglutide and tirzepatide (Ozempic and Mounjaro) and mitigate side effect profile. Still years to go.

Medical Mythbusting Commentary for September 11, 2025

Source:
Scientists create new drug that could be the ‘next Ozempic’… it’s twice as effective without nasty side effects

Related posts:

  1. Treatments for weight loss do exist, work well for many, and reveal our growing understanding of how our homeostatic, motivational, and executive brain centers interact with respect to weight control.
  2. Diabetes drug in short supply in U.S. (but not in Canada) after celebrities, influencers touted its weight-loss benefits.
  3. Meta-analyses of randomized controlled trials looks at efficacy of semaglutide (Ozempic) in treating people suffering with obesity
  4. Addition of fibrates to conventional treatments does not reduce heart attack risk in type II diabetics